{"entity":{"type":"insider","cik":"0001446125","url":"/insider/0001446125","json_url":"/insider/0001446125.json","name":"Greenstreet Yvonne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":163,"n_filings":29,"first":"2018-03-28","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Greenstreet Yvonne","source":"filing","n_filings":29,"first_seen":"2018-03-28","last_seen":"2026-03-06"}],"transactions":[{"id":6078545,"accession":"0001735276-26-000062","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":973.0,"shares_display":"973","price_per_share":323.84,"price_display":"323.84","price_state":"stated","total_value":315096.32,"total_display":"315,096.32","shares_owned_after":96305.0,"shares_owned_after_display":"96,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078543,"accession":"0001735276-26-000062","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":444.0,"shares_display":"444","price_per_share":323.01,"price_display":"323.01","price_state":"stated","total_value":143416.44,"total_display":"143,416.44","shares_owned_after":97278.0,"shares_owned_after_display":"97,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078541,"accession":"0001735276-26-000062","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":368.0,"shares_display":"368","price_per_share":321.82,"price_display":"321.82","price_state":"stated","total_value":118429.76,"total_display":"118,429.76","shares_owned_after":97722.0,"shares_owned_after_display":"97,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078539,"accession":"0001735276-26-000062","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":324.88,"price_display":"324.88","price_state":"stated","total_value":112083.6,"total_display":"112,083.60","shares_owned_after":95960.0,"shares_owned_after_display":"95,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078537,"accession":"0001735276-26-000062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":320.81,"price_display":"320.81","price_state":"stated","total_value":87901.94,"total_display":"87,901.94","shares_owned_after":98090.0,"shares_owned_after_display":"98,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078536,"accession":"0001735276-26-000062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":265.0,"shares_display":"265","price_per_share":325.67,"price_display":"325.67","price_state":"stated","total_value":86302.55,"total_display":"86,302.55","shares_owned_after":95695.0,"shares_owned_after_display":"95,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078534,"accession":"0001735276-26-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":319.03,"price_display":"319.03","price_state":"stated","total_value":43069.05,"total_display":"43,069.05","shares_owned_after":98493.0,"shares_owned_after_display":"98,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6078532,"accession":"0001735276-26-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001735276-26-000062","line_url":"/filing/0001735276-26-000062#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129.0,"shares_display":"129","price_per_share":320.01,"price_display":"320.01","price_state":"stated","total_value":41281.29,"total_display":"41,281.29","shares_owned_after":98364.0,"shares_owned_after_display":"98,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":5815726,"accession":"0001735276-26-000048","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1669.0,"shares_display":"1,669","price_per_share":326.81,"price_display":"326.81","price_state":"stated","total_value":545445.89,"total_display":"545,445.89","shares_owned_after":102078.0,"shares_owned_after_display":"102,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815725,"accession":"0001735276-26-000048","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1399.0,"shares_display":"1,399","price_per_share":327.67,"price_display":"327.67","price_state":"stated","total_value":458410.33,"total_display":"458,410.33","shares_owned_after":100679.0,"shares_owned_after_display":"100,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815723,"accession":"0001735276-26-000048","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1098.0,"shares_display":"1,098","price_per_share":325.63,"price_display":"325.63","price_state":"stated","total_value":357541.74,"total_display":"357,541.74","shares_owned_after":103747.0,"shares_owned_after_display":"103,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815722,"accession":"0001735276-26-000048","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":722.0,"shares_display":"722","price_per_share":329.71,"price_display":"329.71","price_state":"stated","total_value":238050.62,"total_display":"238,050.62","shares_owned_after":99533.0,"shares_owned_after_display":"99,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815720,"accession":"0001735276-26-000048","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424.0,"shares_display":"424","price_per_share":328.71,"price_display":"328.71","price_state":"stated","total_value":139373.04,"total_display":"139,373.04","shares_owned_after":100255.0,"shares_owned_after_display":"100,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815719,"accession":"0001735276-26-000048","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":331.93,"price_display":"331.93","price_state":"stated","total_value":132440.07,"total_display":"132,440.07","shares_owned_after":98788.0,"shares_owned_after_display":"98,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815717,"accession":"0001735276-26-000048","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":382.0,"shares_display":"382","price_per_share":324.65,"price_display":"324.65","price_state":"stated","total_value":124016.3,"total_display":"124,016.30","shares_owned_after":104845.0,"shares_owned_after_display":"104,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815715,"accession":"0001735276-26-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":346.0,"shares_display":"346","price_per_share":330.85,"price_display":"330.85","price_state":"stated","total_value":114474.1,"total_display":"114,474.10","shares_owned_after":99187.0,"shares_owned_after_display":"99,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815713,"accession":"0001735276-26-000048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":323.62,"price_display":"323.62","price_state":"stated","total_value":64724.0,"total_display":"64,724.00","shares_owned_after":105227.0,"shares_owned_after_display":"105,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5815711,"accession":"0001735276-26-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000048","line_url":"/filing/0001735276-26-000048#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160.0,"shares_display":"160","price_per_share":332.64,"price_display":"332.64","price_state":"stated","total_value":53222.4,"total_display":"53,222.40","shares_owned_after":98628.0,"shares_owned_after_display":"98,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5910919,"accession":"0001735276-26-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000028","line_url":"/filing/0001735276-26-000028#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6958.0,"shares_display":"6,958","price_per_share":310.0808,"price_display":"310.08","price_state":"stated","total_value":2157542.2064,"total_display":"2,157,542.21","shares_owned_after":85662.0,"shares_owned_after_display":"85,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":6003956,"accession":"0001735276-26-000014","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-22","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1395.0,"shares_display":"1,395","price_per_share":365.56,"price_display":"365.56","price_state":"stated","total_value":509956.2,"total_display":"509,956.20","shares_owned_after":80264.0,"shares_owned_after_display":"80,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003953,"accession":"0001735276-26-000014","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1259.0,"shares_display":"1,259","price_per_share":364.83,"price_display":"364.83","price_state":"stated","total_value":459320.97,"total_display":"459,320.97","shares_owned_after":81659.0,"shares_owned_after_display":"81,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003951,"accession":"0001735276-26-000014","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":360.22,"price_display":"360.22","price_state":"stated","total_value":353015.6,"total_display":"353,015.60","shares_owned_after":84307.0,"shares_owned_after_display":"84,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003948,"accession":"0001735276-26-000014","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":778.0,"shares_display":"778","price_per_share":358.18,"price_display":"358.18","price_state":"stated","total_value":278664.04,"total_display":"278,664.04","shares_owned_after":85824.0,"shares_owned_after_display":"85,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003946,"accession":"0001735276-26-000014","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":361.45,"price_display":"361.45","price_state":"stated","total_value":225544.8,"total_display":"225,544.80","shares_owned_after":83683.0,"shares_owned_after_display":"83,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003945,"accession":"0001735276-26-000014","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":607.0,"shares_display":"607","price_per_share":357.17,"price_display":"357.17","price_state":"stated","total_value":216802.19,"total_display":"216,802.19","shares_owned_after":86602.0,"shares_owned_after_display":"86,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003942,"accession":"0001735276-26-000014","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":584.0,"shares_display":"584","price_per_share":368.62,"price_display":"368.62","price_state":"stated","total_value":215274.08,"total_display":"215,274.08","shares_owned_after":79103.0,"shares_owned_after_display":"79,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003940,"accession":"0001735276-26-000014","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":537.0,"shares_display":"537","price_per_share":359.14,"price_display":"359.14","price_state":"stated","total_value":192858.18,"total_display":"192,858.18","shares_owned_after":85287.0,"shares_owned_after_display":"85,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003938,"accession":"0001735276-26-000014","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":464.0,"shares_display":"464","price_per_share":362.38,"price_display":"362.38","price_state":"stated","total_value":168144.32,"total_display":"168,144.32","shares_owned_after":83219.0,"shares_owned_after_display":"83,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003935,"accession":"0001735276-26-000014","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":316.0,"shares_display":"316","price_per_share":366.41,"price_display":"366.41","price_state":"stated","total_value":115785.56,"total_display":"115,785.56","shares_owned_after":79948.0,"shares_owned_after_display":"79,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003933,"accession":"0001735276-26-000014","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":301.0,"shares_display":"301","price_per_share":363.55,"price_display":"363.55","price_state":"stated","total_value":109428.55,"total_display":"109,428.55","shares_owned_after":82918.0,"shares_owned_after_display":"82,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003930,"accession":"0001735276-26-000014","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":269.0,"shares_display":"269","price_per_share":355.16,"price_display":"355.16","price_state":"stated","total_value":95538.04,"total_display":"95,538.04","shares_owned_after":87472.0,"shares_owned_after_display":"87,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003928,"accession":"0001735276-26-000014","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":263.0,"shares_display":"263","price_per_share":356.09,"price_display":"356.09","price_state":"stated","total_value":93651.67,"total_display":"93,651.67","shares_owned_after":87209.0,"shares_owned_after_display":"87,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003926,"accession":"0001735276-26-000014","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261.0,"shares_display":"261","price_per_share":367.4,"price_display":"367.40","price_state":"stated","total_value":95891.4,"total_display":"95,891.40","shares_owned_after":79687.0,"shares_owned_after_display":"79,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003922,"accession":"0001735276-26-000014","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253.0,"shares_display":"253","price_per_share":369.48,"price_display":"369.48","price_state":"stated","total_value":93478.44,"total_display":"93,478.44","shares_owned_after":78850.0,"shares_owned_after_display":"78,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003920,"accession":"0001735276-26-000014","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247.0,"shares_display":"247","price_per_share":353.95,"price_display":"353.95","price_state":"stated","total_value":87425.65,"total_display":"87,425.65","shares_owned_after":87741.0,"shares_owned_after_display":"87,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003918,"accession":"0001735276-26-000014","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118.0,"shares_display":"118","price_per_share":375.65,"price_display":"375.65","price_state":"stated","total_value":44326.7,"total_display":"44,326.70","shares_owned_after":78505.0,"shares_owned_after_display":"78,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003915,"accession":"0001735276-26-000014","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118.0,"shares_display":"118","price_per_share":370.87,"price_display":"370.87","price_state":"stated","total_value":43762.66,"total_display":"43,762.66","shares_owned_after":78732.0,"shares_owned_after_display":"78,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003912,"accession":"0001735276-26-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":377.82,"price_display":"377.82","price_state":"stated","total_value":35515.08,"total_display":"35,515.08","shares_owned_after":78411.0,"shares_owned_after_display":"78,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003909,"accession":"0001735276-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":374.44,"price_display":"374.44","price_state":"stated","total_value":32950.72,"total_display":"32,950.72","shares_owned_after":78623.0,"shares_owned_after_display":"78,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6003906,"accession":"0001735276-26-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000014","line_url":"/filing/0001735276-26-000014#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":372.46,"price_display":"372.46","price_state":"stated","total_value":7821.66,"total_display":"7,821.66","shares_owned_after":78711.0,"shares_owned_after_display":"78,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4439814,"accession":"0001735276-25-000120","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-23","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2218.0,"shares_display":"2,218","price_per_share":450.69,"price_display":"450.69","price_state":"stated","total_value":999630.42,"total_display":"999,630.42","shares_owned_after":70047.0,"shares_owned_after_display":"70,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439811,"accession":"0001735276-25-000120","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-22","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1702.0,"shares_display":"1,702","price_per_share":451.94,"price_display":"451.94","price_state":"stated","total_value":769201.88,"total_display":"769,201.88","shares_owned_after":68345.0,"shares_owned_after_display":"68,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439807,"accession":"0001735276-25-000120","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1599.0,"shares_display":"1,599","price_per_share":452.85,"price_display":"452.85","price_state":"stated","total_value":724107.15,"total_display":"724,107.15","shares_owned_after":66746.0,"shares_owned_after_display":"66,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439802,"accession":"0001735276-25-000120","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1477.0,"shares_display":"1,477","price_per_share":450.02,"price_display":"450.02","price_state":"stated","total_value":664679.54,"total_display":"664,679.54","shares_owned_after":72265.0,"shares_owned_after_display":"72,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439795,"accession":"0001735276-25-000120","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1013.0,"shares_display":"1,013","price_per_share":448.76,"price_display":"448.76","price_state":"stated","total_value":454593.88,"total_display":"454,593.88","shares_owned_after":73742.0,"shares_owned_after_display":"73,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439791,"accession":"0001735276-25-000120","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":881.0,"shares_display":"881","price_per_share":453.99,"price_display":"453.99","price_state":"stated","total_value":399965.19,"total_display":"399,965.19","shares_owned_after":65865.0,"shares_owned_after_display":"65,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439786,"accession":"0001735276-25-000120","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":654.0,"shares_display":"654","price_per_share":447.73,"price_display":"447.73","price_state":"stated","total_value":292815.42,"total_display":"292,815.42","shares_owned_after":74755.0,"shares_owned_after_display":"74,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439782,"accession":"0001735276-25-000120","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261.0,"shares_display":"261","price_per_share":456.03,"price_display":"456.03","price_state":"stated","total_value":119023.83,"total_display":"119,023.83","shares_owned_after":65409.0,"shares_owned_after_display":"65,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439778,"accession":"0001735276-25-000120","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195.0,"shares_display":"195","price_per_share":454.69,"price_display":"454.69","price_state":"stated","total_value":88664.55,"total_display":"88,664.55","shares_owned_after":65670.0,"shares_owned_after_display":"65,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4439770,"accession":"0001735276-25-000120","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-25-000120","line_url":"/filing/0001735276-25-000120#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001446125","owner_name":"Greenstreet Yvonne","owner_url":"/insider/0001446125","role":"Director, Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3406.0,"shares_display":"3,406","price_per_share":455.56,"price_display":"455.56","price_state":"stated","total_value":1551637.36,"total_display":"1,551,637.36","shares_owned_after":68863.0,"shares_owned_after_display":"68,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"}],"next_cursor":"2025-11-12|4439770","ledger_fault":false,"count":{"value":163,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":163,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":163},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Director, Officer (Chief Executive Officer)","n_filings":29,"first_seen":"2018-03-28","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001446125","retrieved_at":"2026-08-21T05:01:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}